These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 875637)

  • 1. Evidence for dopamine receptors in the human brain mediating sedation and sleep.
    Corsini GU; Del Zompo M; Manconi S; Piccardi MP; Onali PL; Mangoni A
    Life Sci; 1977 May; 20(9):1613-8. PubMed ID: 875637
    [No Abstract]   [Full Text] [Related]  

  • 2. Self-inhibitory dopamine receptors: their role in the biochemical and behavioral effects of low doses of apomorphine.
    Di Chiara G; Corsini GU; Mereu GP; Tissari A; Gessa GL
    Adv Biochem Psychopharmacol; 1978; 19():275-92. PubMed ID: 358782
    [No Abstract]   [Full Text] [Related]  

  • 3. Self-inhibitory dopamine-receptors and central effects of apomorphine.
    Di Chiara G; Porceddu ML; Morelli M; Gessa GL
    Ann Ist Super Sanita; 1978; 14(1):111-22. PubMed ID: 756166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sedation and sleep induced by high doses of apomorphine after blockade of D-1 receptors by SCH 23390.
    Gessa GL; Porceddu ML; Collu M; Mereu G; Serra M; Ongini E; Biggio G
    Eur J Pharmacol; 1985 Feb; 109(2):269-74. PubMed ID: 2859998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. REM sleep deprivation induces subsensitivity of dopamine receptors mediating sedation in rats.
    Serra G; Melis MR; Argiolas A; Fadda F; Gessa GL
    Eur J Pharmacol; 1981 Jun; 72(1):131-5. PubMed ID: 7262191
    [No Abstract]   [Full Text] [Related]  

  • 6. The supersensitivity of dopaminergic neurons to apomorphine in rats following chronic haloperidol.
    Vogelsang GD; Piercey MF
    Eur J Pharmacol; 1985 Apr; 110(2):267-9. PubMed ID: 3987817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unique response to antipsychotic drugs is due to absence of terminal autoreceptors in mesocortical dopamine neurones.
    Bannon MJ; Reinhard JF; Bunney EB; Roth RH
    Nature; 1982 Apr; 296(5856):444-6. PubMed ID: 7063040
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacological evidence against the involvement of the D1 subtype of dopamine receptors in apomorphine-induced hypothermia.
    Colboc O; Protais P; Costentin J
    Neurosci Lett; 1983 Aug; 39(2):211-6. PubMed ID: 6633953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ventral tegmental area: site through which dopamine D2-receptor agonists evoke behavioural and electrocortical sleep in rats.
    Bagetta G; De Sarro G; Priolo E; Nisticò G
    Br J Pharmacol; 1988 Nov; 95(3):860-6. PubMed ID: 2974741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral, anti-dopaminergic, and prohypnotic effects of neuroleptics during and after prolonged treatment.
    Biazzi A; Fregnan GB
    Adv Biochem Psychopharmacol; 1980; 24():351-7. PubMed ID: 6105785
    [No Abstract]   [Full Text] [Related]  

  • 11. Gamma-type endorphins and brain dopaminergic systems.
    van Ree JM; Elands J; Kiraly I; Wolterink G
    Prog Clin Biol Res; 1990; 328():287-90. PubMed ID: 1968266
    [No Abstract]   [Full Text] [Related]  

  • 12. Substance P levels in the rat forebrain after apomorphine and haloperidol treatment.
    Janicki P; Lypko A; Szczudlik A; Libich J
    Pol J Pharmacol Pharm; 1981; 33(5):499-502. PubMed ID: 6174959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine synthesis: tolerance to haloperidol and supersensitivity to apomorphine depend on presynaptic receptors.
    Biggio G; Casu M; Klimek V; Gessa GL
    Adv Biochem Psychopharmacol; 1980; 24():17-22. PubMed ID: 6996441
    [No Abstract]   [Full Text] [Related]  

  • 14. Changes in the sensitivities of dopamine receptors to chronic treatment with imipramine & haloperidol in rats.
    Pradhan N; Arunasmitha AS
    Indian J Med Res; 1990 Aug; 92():293-7. PubMed ID: 2228076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evidence for multiple dopamine receptors in man.
    Meltzer HY
    Commun Psychopharmacol; 1979; 3(6):457-70. PubMed ID: 44694
    [No Abstract]   [Full Text] [Related]  

  • 16. Imaging CNS receptors: the dopaminergic system.
    Wagner HN
    Hosp Pract (Off Ed); 1984 Jun; 19(6):187-91, 195-8, 202. PubMed ID: 6144688
    [No Abstract]   [Full Text] [Related]  

  • 17. Function of nigral dopamine receptors?
    Glick SD; Crane LA
    Brain Res; 1978 Nov; 156(2):380-1. PubMed ID: 568507
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of haloperidol and apomorphine treatment on dopamine receptors in pituitary and striatum.
    Friend WC; Brown GM; Jawahir G; Lee T; Seeman P
    Am J Psychiatry; 1978 Jul; 135(7):839-41. PubMed ID: 665797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apomorphine as a preferential stimulant of self-inhibitory dopamine receptors in man.
    Corsini GU; Del Zompo M; Piccardi MP; Mangoni A; Gessa GL
    Ann Ist Super Sanita; 1978; 14(1):123-30. PubMed ID: 756167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple receptors for brain dopamine in behavior regulation: concept of dopamine-E and dopamine-I receptors.
    Cools AR; van Rossum JM
    Life Sci; 1980 Oct; 27(14):1237-53. PubMed ID: 6255271
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.